Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Layton

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Blut|January 1, 1988
Sweet's syndrome and myelodysplasiaD K Knight, D M Layton, G J Mufti, et al.
The British Journal of Surgery|May 1, 1991
Safe surgery in sickle cell diseaseA K Banerjee, D M Layton, J A Rennie, et al.
Leukemia Research|January 1, 1987
Myelodysplastic relapse of de-novo AML: a heterogeneous entity?D M Layton, R M Ireland, G J Mufti, et al.
American Journal of Obstetrics and Gynecology|May 1, 1993
Fetal plasma interferon gamma concentration in normal pregnancyA Abbas, B Thilaganathan, A G Buggins, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 26, 2004
Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell diseaseS F Ofori-Acquah, M R A Lalloz, G Serjeant, et al.
Clinical and Experimental Immunology|November 1, 1992
Analysis of lymphocyte phenotypes in cord blood from early gestation fetusesM Peakman, A G Buggins, K H Nicolaides, et al.
Leukemia|July 1, 1990
Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemiaK Tobal, A Pagliuca, B Bhatt, et al.
Human Molecular Genetics|March 1, 1993
DNA sequence abnormalities in human glucose 6-phosphate isomerase deficiencyJ I Walker, D M Layton, A J Bellingham, et al.
Journal of the Royal Society of Medicine|May 1, 1994
Disseminated Trichosporon beigelii infection in an immunosuppressed childE M Higgins, D M Layton, R Arya, et al.
The New England Journal of Medicine|June 2, 1988
Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapyD M Layton, G J Mufti, J Lyons, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Blut|January 1, 1988
Sweet's syndrome and myelodysplasiaD K Knight, D M Layton, G J Mufti, et al.
The British Journal of Surgery|May 1, 1991
Safe surgery in sickle cell diseaseA K Banerjee, D M Layton, J A Rennie, et al.
Leukemia Research|January 1, 1987
Myelodysplastic relapse of de-novo AML: a heterogeneous entity?D M Layton, R M Ireland, G J Mufti, et al.
American Journal of Obstetrics and Gynecology|May 1, 1993
Fetal plasma interferon gamma concentration in normal pregnancyA Abbas, B Thilaganathan, A G Buggins, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 26, 2004
Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell diseaseS F Ofori-Acquah, M R A Lalloz, G Serjeant, et al.
Clinical and Experimental Immunology|November 1, 1992
Analysis of lymphocyte phenotypes in cord blood from early gestation fetusesM Peakman, A G Buggins, K H Nicolaides, et al.
Leukemia|July 1, 1990
Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemiaK Tobal, A Pagliuca, B Bhatt, et al.
Human Molecular Genetics|March 1, 1993
DNA sequence abnormalities in human glucose 6-phosphate isomerase deficiencyJ I Walker, D M Layton, A J Bellingham, et al.
Journal of the Royal Society of Medicine|May 1, 1994
Disseminated Trichosporon beigelii infection in an immunosuppressed childE M Higgins, D M Layton, R Arya, et al.
The New England Journal of Medicine|June 2, 1988
Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapyD M Layton, G J Mufti, J Lyons, et al.
Pageof 6